Discussing Vaborem▼ (meropenem/vaborbactam) - the what, where and why - US and UK experience.

Thursday 4th March 2021


Meeting chair: Prof. Alistair Leanord


4th March 2021
17:00 Introduction and Epidemiology of KPC in Scotland
Prof. Alistair Leanord
17:15 Treating KPC-producing Gram-negative infection- Lessons from the US
Prof. Ryan Shields
17:40 KPC in COVID times
Dr Louise Sweeney
18:00 Q&A
All speakers
18:15 Closing Remarks
Prof. Alistair Leanord

Speakers & Chairs

Prof. Alistair Leanord
Consultant Microbiologist, Queen Elizabeth University Hospital, Glasgow
Prof. Ryan Shields
Associate Professor of Medicine, University of Pittsburgh.
Dr Louise Sweeney
Consultant Microbiologist, Royal Liverpool University Hospital

Who should attend?

UK healthcare professionals only with an interest in infection and treatment pathways.
Please do not share or send this invitation to anyone.


Registration is now open, and free to attend for UK healthcare professionals with an interest in serious gram negative infections. Please complete the form below.

Please ensure members of the public are not able to see or hear the content of this meeting.
Prescribing Information will be available during the webinar.

This is a medical education meeting organised and funded by A.Menarini Farmaceutica Internazionale SRL and is intended for UK Healthcare Professionals only.

If you would like to hear from A. Menarini Farmaceutica Internationale Srl about our products and future meetings, please click here.

Adverse events should be reported Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to A. Menarini Farmaceutica Internazionale SRL. Phone no. 0800 085 8678 or email: menarini@medinformation.co.uk

Date of Preparation- February 2021.


    Job Role


    Contact Email

    By registering for this meeting, I confirm that I am a healthcare professional resident in the UK and I consent to the sharing of my attendance details with A. Menarini Farmaceutica Internazionale S.r.l.